Venmax Drugs and Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 511,000 compared to INR 0 a year ago. Net loss was INR 425,000 compared to INR 156,000 a year ago. Basic loss per share was INR 0.08 compared to INR 0.03 a year ago. For the nine months, total revenue was INR 644,000 compared to INR 0 a year ago. Net loss was INR 1.503 million compared to INR 686,000 a year ago. Basic loss per share was INR 0.29 compared to INR 0.13 a year ago.